Status:
COMPLETED
Pivotal Influence of Obesity on Body Composition and Ovarian Doppler in Different Polycystic Ovarian Syndrome Phenotypes
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Helwan University
National Research Centre, Egypt
Conditions:
Polycystic Ovary Syndrome
Obesity
Eligibility:
FEMALE
18-40 years
Brief Summary
The study aimed to explore the impact of obesity on both body composition and ovarian Doppler parameters across various phenotypes of females diagnosed with polycystic ovarian syndrome (PCOS). Additio...
Detailed Description
Polycystic ovarian syndrome (PCOS) is a complex and multifactorial condition characterized by endocrinological, reproductive, metabolic, and biochemical abnormalities, affecting 12% to 21% of reproduc...
Eligibility Criteria
Inclusion
- Age ranged from 18 to 40 years old.
- Individuals with Polycystic Ovary Syndrome (PCOS) should exhibit at least two of the three features outlined in the Rotterdam criteria for diagnosis, encompassing oligo- or anovulation, clinical and/or biochemical indications of hyperandrogenism, and the presence of polycystic ovaries as identified through ultrasonography.
Exclusion
- Congenital adrenal hyperplasia
- Thyroid dysfunction
- Hyperprolactinemia
- Androgen-secreting tumors
- Cushing syndrome
- Undergoing any medical therapy for the treatment of PCOS or for weight loss.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06164132
Start Date
July 1 2023
End Date
October 31 2023
Last Update
February 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Giza, Egypt